The implantable cardioverter-defibrillator (ICD) is a proven treatment for preventing sudden
cardiac death. Transvenous leads are associated with significant mortality and morbidity …

The trans-venous implantable cardioverter defibrillator (TV-ICD) is effective in treating life-
threatening ventricular arrhythmia and reduces mortality in high-risk patients. However …

Background: Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival
in patients at risk for sudden cardiac death, but complications remain an important …

The implantable cardioverter-defibrillator (ICD) is an established tool to treat survivors of
cardiac arrest due to ventricular arrhythmia or patients deemed to be at high risk for sudden …

Over the past decade, the emergence of the subcutaneous implantable cardioverter
defibrillator (S‐ICD) has provided cardiologists with an option to provide both primary or …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has been
designed to overcome lead-related complications and device endocarditis. Lacking the …

Background: Lead-related complication is an important drawback of trans-venous
implantable cardioverter-defibrillators (TV-ICD). The subcutaneous ICD (S-ICD) was …

Background Implantable cardioverter-defibrillator (ICD) placement is a well-established
therapy for prevention of sudden cardiac death. The subcutaneous implantable cardioverter …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) has recently been approved
for commercial use in Europe, New Zealand and the United States. It is comprised of a pulse …

Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of
great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV …